Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Gardner, Eliot L."'
Autor:
Xi ZX; Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA., Muldoon P; Department of Anatomy and Neurobiology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Wang XF; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China., Bi GH; Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA., Damaj MI; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA., Lichtman AH; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA., Pertwee RG; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK., Gardner EL; Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2019 Dec; Vol. 176 (24), pp. 4773-4784. Date of Electronic Publication: 2019 Oct 28.
Autor:
He XH; Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, 21224, USA.; Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China., Jordan CJ; Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, 21224, USA., Vemuri K; Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA.; Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA, 02115, USA., Bi GH; Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, 21224, USA., Zhan J; Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, 21224, USA.; Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China., Gardner EL; Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, 21224, USA., Makriyannis A; Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA.; Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA, 02115, USA., Wang YL; Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. wyl0342@sina.com., Xi ZX; Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, 21224, USA. zxi@mail.nih.gov.
Publikováno v:
Acta pharmacologica Sinica [Acta Pharmacol Sin] 2019 Mar; Vol. 40 (3), pp. 365-373. Date of Electronic Publication: 2018 Jul 02.
Autor:
You ZB; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA., Gao JT; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA., Bi GH; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA., He Y; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA., Boateng C; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA., Cao J; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA., Gardner EL; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA., Newman AH; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA. Electronic address: amy.newman@nih.gov., Xi ZX; Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA. Electronic address: zxi@mail.nih.gov.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2017 Nov; Vol. 126, pp. 190-199. Date of Electronic Publication: 2017 Sep 06.
Autor:
Zhang HY; Neuropsychopharmacology Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.; Medication Development Program, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Bi GH; Neuropsychopharmacology Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.; Medication Development Program, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Yang HJ; Neuropsychopharmacology Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., He Y; Neuropsychopharmacology Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Xue G; Neuropsychopharmacology Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Cao J; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Tanda G; Medication Development Program, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Gardner EL; Neuropsychopharmacology Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Newman AH; Medication Development Program, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Xi ZX; Neuropsychopharmacology Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.; Medication Development Program, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2017 Aug; Vol. 42 (9), pp. 1871-1883. Date of Electronic Publication: 2017 Mar 07.
Autor:
Wang XF; Neuropsychopharmacology Section, Molecular Target and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Bi GH; Neuropsychopharmacology Section, Molecular Target and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., He Y; Neuropsychopharmacology Section, Molecular Target and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Yang HJ; Neuropsychopharmacology Section, Molecular Target and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Gao JT; Neuropsychopharmacology Section, Molecular Target and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Okunola-Bakare OM; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Slack RD; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Gardner EL; Neuropsychopharmacology Section, Molecular Target and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Xi ZX; Neuropsychopharmacology Section, Molecular Target and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Newman AH; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2015 Jun; Vol. 40 (7), pp. 1762-71. Date of Electronic Publication: 2015 Jan 23.
Autor:
Keck TM; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse. NIH, DHHS, Baltimore, MD, USA., Zou MF, Bi GH, Zhang HY, Wang XF, Yang HJ, Srivastava R, Gardner EL, Xi ZX, Newman AH
Publikováno v:
Addiction biology [Addict Biol] 2014 Mar; Vol. 19 (2), pp. 195-209. Date of Electronic Publication: 2013 Sep 04.
Autor:
Song R; Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224, USA; Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China., Bi GH; Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224, USA., Zhang HY; Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224, USA., Yang RF; Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China., Gardner EL; Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224, USA., Li J; Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China. Electronic address: jinli9802@163.com., Xi ZX; Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224, USA. Electronic address: zxi@intra.nida.nih.gov.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2014 Feb; Vol. 77, pp. 398-405. Date of Electronic Publication: 2013 Oct 28.
Autor:
Keck TM; Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, Baltimore, MD 21224, USA., Yang HJ, Bi GH, Huang Y, Zhang HY, Srivastava R, Gardner EL, Newman AH, Xi ZX
Publikováno v:
Psychopharmacology [Psychopharmacology (Berl)] 2013 Sep; Vol. 229 (2), pp. 253-65. Date of Electronic Publication: 2013 Apr 25.
Autor:
Srivastava R; National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA. ratika.srivastava@nih.gov, Xi ZX, Gardner EL
Publikováno v:
Neuroscience letters [Neurosci Lett] 2012 Feb 06; Vol. 508 (2), pp. 106-9. Date of Electronic Publication: 2011 Dec 22.